chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Paranasal sinus discomfort, SARS-CoV-2 test positive, Sinus headache
Clinical narrative: 3/21/2023   Woke up with a severe cough, fatigue and an on again off again sinus pressure headache.  Tested with At Home COVID-19 test, positive.  3/22, coughing severely and loss of voice. 3/23 Televisit with Doctor who proscribed Paxlovid, Prednisone, and Promethazine DM.  Doctor recommended albuterol, but allergist recommended increased dose of Symbicort.   Coughing subsided by the weekend, 3/25.  Symptoms gradually diminished until 3/25, but the fatigue lingered another week.  Brain Fog lingers to the time of reporting.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Cough, Pain, Pyrexia
Clinical narrative: On 04/01 I contacted the medical group. I had severe cough, low grade temperature, chills, congestion body aches and a fever. The doctor started treating the with two extra strength TYLENOL and PAXLOVID, tromethamine DM lots of water and rest. I was told to retest 5 more day and I tested on the 5th day and was negative. I still have a little cough which I think it's just allergies.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: On 04/01 I contacted the medical group. I had severe cough, low grade temperature, chills, congestion body aches and a fever. The doctor started treating the with two extra strength TYLENOL and PAXLOVID, tromethamine DM lots of water and rest. I was told to retest 5 more day and I tested on the 5th day and was negative. I still have a little cough which I think it's just allergies.
Age: 69.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Chills, Cough, Decreased appetite, Influenza virus test negative
Clinical narrative: I thought I was getting a cold, I had congestion, fever, chills, lost my appetite, I had a fever. I used a home COVID-19 test that came back wasn't really clear, I made an appointment with my doctor to go in to find out if it was the flu or COVID-19. I was tested for both COVID-19 and Influenza, the COVID-19 came back positive. I was at day five of my symptoms when I went into the doctor's office. I was given medication for my cough. It took three weeks for the nasal congestion to go away, the cough did go away in two weeks.
Age: 69.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Nasal congestion, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: I thought I was getting a cold, I had congestion, fever, chills, lost my appetite, I had a fever. I used a home COVID-19 test that came back wasn't really clear, I made an appointment with my doctor to go in to find out if it was the flu or COVID-19. I was tested for both COVID-19 and Influenza, the COVID-19 came back positive. I was at day five of my symptoms when I went into the doctor's office. I was given medication for my cough. It took three weeks for the nasal congestion to go away, the cough did go away in two weeks.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Pfizer 5/1/21 Lot# Ew0185;  Pfizer 6/3/21 Lot# Ew0191
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Electrocardiogram, Fatigue, Headache
Clinical narrative: I tested positive for Covid 19 on April 1, 2023 I experienced sinus congestion; cough; tired; headache; oxygen level was 83% I was prescribed Paxlovid for my symptoms.
Age: 68.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: I tested positive for Covid 19 on April 1, 2023 I experienced sinus congestion; cough; tired; headache; oxygen level was 83% I was prescribed Paxlovid for my symptoms.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19 pneumonia, Hypoxia, Myocardial ischaemia, Oesophageal adenocarcinoma
Clinical narrative: DEMAND ISCHEMIA 10/2/2021 COVID-19 PNEUMONIA ACUTE RESPIRATORY FAILURE 10/10/2021 COVID-19 PNEUMONIA ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/21/2021 COVID-19 PNEUMONIA HYPOXIA 9/7/2021 COVID-19 PNEUMONIA DEMAND ISCHEMIA 10/2/2021 ADENOCARCINOMA, LOWER THIRD OF ESOPHAGUS ACUTE RESPIRATORY FAILURE 10/10/2021 ADENOCARCINOMA, LOWER THIRD OF ESOPHAGUS ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/21/2021 ADENOCARCINOMA, LOWER THIRD OF ESOPHAGUS HYPOXIA 9/7/2021 ADENOCARCINOMA, LOWER THIRD OF ESOPHAGUS DEMAND ISCHEMIA 10/2/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION ACUTE RESPIRATORY FAILURE 10/10/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/21/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION HYPOXIA 9/7/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis
Clinical narrative: DEMAND ISCHEMIA 10/2/2021 COVID-19 PNEUMONIA ACUTE RESPIRATORY FAILURE 10/10/2021 COVID-19 PNEUMONIA ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/21/2021 COVID-19 PNEUMONIA HYPOXIA 9/7/2021 COVID-19 PNEUMONIA DEMAND ISCHEMIA 10/2/2021 ADENOCARCINOMA, LOWER THIRD OF ESOPHAGUS ACUTE RESPIRATORY FAILURE 10/10/2021 ADENOCARCINOMA, LOWER THIRD OF ESOPHAGUS ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/21/2021 ADENOCARCINOMA, LOWER THIRD OF ESOPHAGUS HYPOXIA 9/7/2021 ADENOCARCINOMA, LOWER THIRD OF ESOPHAGUS DEMAND ISCHEMIA 10/2/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION ACUTE RESPIRATORY FAILURE 10/10/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION ACUTE HYPOXEMIC RESPIRATORY FAILURE 9/21/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION HYPOXIA 9/7/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION
Age: 11.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: NONE: Vaccine Expired 10/25/2023, given 02/06/2023
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test abnormal, COVID-19, Contusion, Cough
Clinical narrative: I tested positive for COVID-19 in August 2022. I had a very high fever with cough and congestion. It lasted about 5 days. I only slept and drank fluids for my treatment. My fever got up to about 104 before it broke. I did have trouble breathing but my pulse oxygen level remained normal. After this I was feeling so very fatigued and bruising very easy with overall weakness. I went to the doctor to find out what was causing this. The tests showed that my platelets were very low and was told to watch for 6 months. After 6 months we tested again, and I am now considered "chronic". The next for me is to have my blood drawn every two weeks to determine any other auto immune issues or deficiencies and blood cancers.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Platelet count decreased, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 in August 2022. I had a very high fever with cough and congestion. It lasted about 5 days. I only slept and drank fluids for my treatment. My fever got up to about 104 before it broke. I did have trouble breathing but my pulse oxygen level remained normal. After this I was feeling so very fatigued and bruising very easy with overall weakness. I went to the doctor to find out what was causing this. The tests showed that my platelets were very low and was told to watch for 6 months. After 6 months we tested again, and I am now considered "chronic". The next for me is to have my blood drawn every two weeks to determine any other auto immune issues or deficiencies and blood cancers.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 3/19/21 Lot# 045A21A;  Moderna 4/16/21 Lot# 016B21A
Age: 31.0
Sex: F
Vaccine: HEPAB
Symptoms: No adverse event
Clinical narrative: No adverse
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 3/7/21 Lot# 030A21A;  Moderna 4/5/21 Lot# 006B21A;  Moderna 12/10/21 Lot# 013F21A
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 2/17/1 Lot# EL9267;  Pfizer 3/6/21 Lot# EN6202;  Pfizer 11/30/21 Lot# FH8027
Age: 16.0
Sex: M
Vaccine: MENB
Symptoms: Unevaluable event
Clinical narrative: none
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Aspiration, Barium swallow abnormal, Blood sodium increased
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/17/2023 Discharge Date: 03/23/2023 PRESENTING PROBLEM: Hypoxia Acute respiratory failure with hypoxia Altered mental status, unspecified altered mental status type Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung COVID-19   HOSPITAL COURSE: Patient is a 76 year old man with hx of CVA with LUE and bilateral lower extremity weakness and hydrocephalus with a VP shunt since 2013. He lives in LTC. He presented with AMS. He had a + covid home test at LTC on 3/13. He had O2 sat in the 70's while at his facility. On arrival to emergency department patient was found to be hypoxic at 88 %, he is placed on 3 L of nasal cannula.  Otherwise patient was hemodynamically stable.  Labs were unremarkable. \Chest x-ray was done showing infiltrate in the retrocardiac left lower lobe suspicious for PNA. CTA was neg for PE, it showed bl lower lobe consolidations.    Patient was given Rocephin and azithromycin in the E.D.  Procal was negative.  CT brain without contrast showed diffuse low-density subdural fluid collection overlying the cerebellar hemispheres and along the interhemispheric falx are larger compared to prior with mild mass effect upon the subjacent brain parenchyma.  Likely due to hygromas and/or chronic hematomas. As well as hyper densities within the paranasal sinuses.   He was admitted for neurosurgery eval. Nsx ordered MRI brain which was unremarkable aside from chronic cva and concern for overshunting. Neurology changed his VP shunt settings from 2.5 to 1.5. He was treated with D5W for hypernatremia due to free water deficit. He was monitored off antibiotics but treated with decadron and remdesivir x 5 days. His hypoxia resolved to room air and mental status normalized.   He was made npo on 3/18 after choking on one of his meds. SLP evaluated and recommended meds in puree otherwise thin liquids and general solids. As sodium normalized, D5W was discontinued. Discharged was initially planned on 3/20 however he had nose bleed and poorly able to cough and clear the blood in his pharynx resulting in worsening respiratory status. He was changed to npo. Unasyn was started due to CXR showing left sided consolidation. SLP was consulted and video swallow was  completed on 03/21/2023 showing mild to moderate oral dysphagia and moderate to severe pharyngeal dysphagia and his diet was changed to a dysphagia diet. He was weaned to room air and transitioned to oral augmentin to complete 5 total days of antibiotics for aspiration/CAP. He discharged back to LTC on 3/23. Decadron was discontinued at discharge (initially started on 3/17) as the patient had been weaned to room air.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cerebral haematoma, Cerebral mass effect, Cerebrospinal fluid retention, Chest X-ray abnormal
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/17/2023 Discharge Date: 03/23/2023 PRESENTING PROBLEM: Hypoxia Acute respiratory failure with hypoxia Altered mental status, unspecified altered mental status type Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung COVID-19   HOSPITAL COURSE: Patient is a 76 year old man with hx of CVA with LUE and bilateral lower extremity weakness and hydrocephalus with a VP shunt since 2013. He lives in LTC. He presented with AMS. He had a + covid home test at LTC on 3/13. He had O2 sat in the 70's while at his facility. On arrival to emergency department patient was found to be hypoxic at 88 %, he is placed on 3 L of nasal cannula.  Otherwise patient was hemodynamically stable.  Labs were unremarkable. \Chest x-ray was done showing infiltrate in the retrocardiac left lower lobe suspicious for PNA. CTA was neg for PE, it showed bl lower lobe consolidations.    Patient was given Rocephin and azithromycin in the E.D.  Procal was negative.  CT brain without contrast showed diffuse low-density subdural fluid collection overlying the cerebellar hemispheres and along the interhemispheric falx are larger compared to prior with mild mass effect upon the subjacent brain parenchyma.  Likely due to hygromas and/or chronic hematomas. As well as hyper densities within the paranasal sinuses.   He was admitted for neurosurgery eval. Nsx ordered MRI brain which was unremarkable aside from chronic cva and concern for overshunting. Neurology changed his VP shunt settings from 2.5 to 1.5. He was treated with D5W for hypernatremia due to free water deficit. He was monitored off antibiotics but treated with decadron and remdesivir x 5 days. His hypoxia resolved to room air and mental status normalized.   He was made npo on 3/18 after choking on one of his meds. SLP evaluated and recommended meds in puree otherwise thin liquids and general solids. As sodium normalized, D5W was discontinued. Discharged was initially planned on 3/20 however he had nose bleed and poorly able to cough and clear the blood in his pharynx resulting in worsening respiratory status. He was changed to npo. Unasyn was started due to CXR showing left sided consolidation. SLP was consulted and video swallow was  completed on 03/21/2023 showing mild to moderate oral dysphagia and moderate to severe pharyngeal dysphagia and his diet was changed to a dysphagia diet. He was weaned to room air and transitioned to oral augmentin to complete 5 total days of antibiotics for aspiration/CAP. He discharged back to LTC on 3/23. Decadron was discontinued at discharge (initially started on 3/17) as the patient had been weaned to room air.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Choking, Computerised tomogram head abnormal, Condition aggravated, Dysphagia, Epistaxis
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/17/2023 Discharge Date: 03/23/2023 PRESENTING PROBLEM: Hypoxia Acute respiratory failure with hypoxia Altered mental status, unspecified altered mental status type Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung COVID-19   HOSPITAL COURSE: Patient is a 76 year old man with hx of CVA with LUE and bilateral lower extremity weakness and hydrocephalus with a VP shunt since 2013. He lives in LTC. He presented with AMS. He had a + covid home test at LTC on 3/13. He had O2 sat in the 70's while at his facility. On arrival to emergency department patient was found to be hypoxic at 88 %, he is placed on 3 L of nasal cannula.  Otherwise patient was hemodynamically stable.  Labs were unremarkable. \Chest x-ray was done showing infiltrate in the retrocardiac left lower lobe suspicious for PNA. CTA was neg for PE, it showed bl lower lobe consolidations.    Patient was given Rocephin and azithromycin in the E.D.  Procal was negative.  CT brain without contrast showed diffuse low-density subdural fluid collection overlying the cerebellar hemispheres and along the interhemispheric falx are larger compared to prior with mild mass effect upon the subjacent brain parenchyma.  Likely due to hygromas and/or chronic hematomas. As well as hyper densities within the paranasal sinuses.   He was admitted for neurosurgery eval. Nsx ordered MRI brain which was unremarkable aside from chronic cva and concern for overshunting. Neurology changed his VP shunt settings from 2.5 to 1.5. He was treated with D5W for hypernatremia due to free water deficit. He was monitored off antibiotics but treated with decadron and remdesivir x 5 days. His hypoxia resolved to room air and mental status normalized.   He was made npo on 3/18 after choking on one of his meds. SLP evaluated and recommended meds in puree otherwise thin liquids and general solids. As sodium normalized, D5W was discontinued. Discharged was initially planned on 3/20 however he had nose bleed and poorly able to cough and clear the blood in his pharynx resulting in worsening respiratory status. He was changed to npo. Unasyn was started due to CXR showing left sided consolidation. SLP was consulted and video swallow was  completed on 03/21/2023 showing mild to moderate oral dysphagia and moderate to severe pharyngeal dysphagia and his diet was changed to a dysphagia diet. He was weaned to room air and transitioned to oral augmentin to complete 5 total days of antibiotics for aspiration/CAP. He discharged back to LTC on 3/23. Decadron was discontinued at discharge (initially started on 3/17) as the patient had been weaned to room air.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fluid retention, Hypernatraemia, Hypoxia, Laboratory test normal, Lung consolidation
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/17/2023 Discharge Date: 03/23/2023 PRESENTING PROBLEM: Hypoxia Acute respiratory failure with hypoxia Altered mental status, unspecified altered mental status type Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung COVID-19   HOSPITAL COURSE: Patient is a 76 year old man with hx of CVA with LUE and bilateral lower extremity weakness and hydrocephalus with a VP shunt since 2013. He lives in LTC. He presented with AMS. He had a + covid home test at LTC on 3/13. He had O2 sat in the 70's while at his facility. On arrival to emergency department patient was found to be hypoxic at 88 %, he is placed on 3 L of nasal cannula.  Otherwise patient was hemodynamically stable.  Labs were unremarkable. \Chest x-ray was done showing infiltrate in the retrocardiac left lower lobe suspicious for PNA. CTA was neg for PE, it showed bl lower lobe consolidations.    Patient was given Rocephin and azithromycin in the E.D.  Procal was negative.  CT brain without contrast showed diffuse low-density subdural fluid collection overlying the cerebellar hemispheres and along the interhemispheric falx are larger compared to prior with mild mass effect upon the subjacent brain parenchyma.  Likely due to hygromas and/or chronic hematomas. As well as hyper densities within the paranasal sinuses.   He was admitted for neurosurgery eval. Nsx ordered MRI brain which was unremarkable aside from chronic cva and concern for overshunting. Neurology changed his VP shunt settings from 2.5 to 1.5. He was treated with D5W for hypernatremia due to free water deficit. He was monitored off antibiotics but treated with decadron and remdesivir x 5 days. His hypoxia resolved to room air and mental status normalized.   He was made npo on 3/18 after choking on one of his meds. SLP evaluated and recommended meds in puree otherwise thin liquids and general solids. As sodium normalized, D5W was discontinued. Discharged was initially planned on 3/20 however he had nose bleed and poorly able to cough and clear the blood in his pharynx resulting in worsening respiratory status. He was changed to npo. Unasyn was started due to CXR showing left sided consolidation. SLP was consulted and video swallow was  completed on 03/21/2023 showing mild to moderate oral dysphagia and moderate to severe pharyngeal dysphagia and his diet was changed to a dysphagia diet. He was weaned to room air and transitioned to oral augmentin to complete 5 total days of antibiotics for aspiration/CAP. He discharged back to LTC on 3/23. Decadron was discontinued at discharge (initially started on 3/17) as the patient had been weaned to room air.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Lung infiltration, Magnetic resonance imaging head abnormal, Mental status changes, Pharyngeal haemorrhage, Pneumonia
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/17/2023 Discharge Date: 03/23/2023 PRESENTING PROBLEM: Hypoxia Acute respiratory failure with hypoxia Altered mental status, unspecified altered mental status type Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung COVID-19   HOSPITAL COURSE: Patient is a 76 year old man with hx of CVA with LUE and bilateral lower extremity weakness and hydrocephalus with a VP shunt since 2013. He lives in LTC. He presented with AMS. He had a + covid home test at LTC on 3/13. He had O2 sat in the 70's while at his facility. On arrival to emergency department patient was found to be hypoxic at 88 %, he is placed on 3 L of nasal cannula.  Otherwise patient was hemodynamically stable.  Labs were unremarkable. \Chest x-ray was done showing infiltrate in the retrocardiac left lower lobe suspicious for PNA. CTA was neg for PE, it showed bl lower lobe consolidations.    Patient was given Rocephin and azithromycin in the E.D.  Procal was negative.  CT brain without contrast showed diffuse low-density subdural fluid collection overlying the cerebellar hemispheres and along the interhemispheric falx are larger compared to prior with mild mass effect upon the subjacent brain parenchyma.  Likely due to hygromas and/or chronic hematomas. As well as hyper densities within the paranasal sinuses.   He was admitted for neurosurgery eval. Nsx ordered MRI brain which was unremarkable aside from chronic cva and concern for overshunting. Neurology changed his VP shunt settings from 2.5 to 1.5. He was treated with D5W for hypernatremia due to free water deficit. He was monitored off antibiotics but treated with decadron and remdesivir x 5 days. His hypoxia resolved to room air and mental status normalized.   He was made npo on 3/18 after choking on one of his meds. SLP evaluated and recommended meds in puree otherwise thin liquids and general solids. As sodium normalized, D5W was discontinued. Discharged was initially planned on 3/20 however he had nose bleed and poorly able to cough and clear the blood in his pharynx resulting in worsening respiratory status. He was changed to npo. Unasyn was started due to CXR showing left sided consolidation. SLP was consulted and video swallow was  completed on 03/21/2023 showing mild to moderate oral dysphagia and moderate to severe pharyngeal dysphagia and his diet was changed to a dysphagia diet. He was weaned to room air and transitioned to oral augmentin to complete 5 total days of antibiotics for aspiration/CAP. He discharged back to LTC on 3/23. Decadron was discontinued at discharge (initially started on 3/17) as the patient had been weaned to room air.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Procalcitonin normal, Respiratory disorder, SARS-CoV-2 test positive, Sputum retention, Subdural hygroma
Clinical narrative: Discharge Provider: MD Primary Care Provider: MD Admission Date: 3/17/2023 Discharge Date: 03/23/2023 PRESENTING PROBLEM: Hypoxia Acute respiratory failure with hypoxia Altered mental status, unspecified altered mental status type Pneumonia due to infectious organism, unspecified laterality, unspecified part of lung COVID-19   HOSPITAL COURSE: Patient is a 76 year old man with hx of CVA with LUE and bilateral lower extremity weakness and hydrocephalus with a VP shunt since 2013. He lives in LTC. He presented with AMS. He had a + covid home test at LTC on 3/13. He had O2 sat in the 70's while at his facility. On arrival to emergency department patient was found to be hypoxic at 88 %, he is placed on 3 L of nasal cannula.  Otherwise patient was hemodynamically stable.  Labs were unremarkable. \Chest x-ray was done showing infiltrate in the retrocardiac left lower lobe suspicious for PNA. CTA was neg for PE, it showed bl lower lobe consolidations.    Patient was given Rocephin and azithromycin in the E.D.  Procal was negative.  CT brain without contrast showed diffuse low-density subdural fluid collection overlying the cerebellar hemispheres and along the interhemispheric falx are larger compared to prior with mild mass effect upon the subjacent brain parenchyma.  Likely due to hygromas and/or chronic hematomas. As well as hyper densities within the paranasal sinuses.   He was admitted for neurosurgery eval. Nsx ordered MRI brain which was unremarkable aside from chronic cva and concern for overshunting. Neurology changed his VP shunt settings from 2.5 to 1.5. He was treated with D5W for hypernatremia due to free water deficit. He was monitored off antibiotics but treated with decadron and remdesivir x 5 days. His hypoxia resolved to room air and mental status normalized.   He was made npo on 3/18 after choking on one of his meds. SLP evaluated and recommended meds in puree otherwise thin liquids and general solids. As sodium normalized, D5W was discontinued. Discharged was initially planned on 3/20 however he had nose bleed and poorly able to cough and clear the blood in his pharynx resulting in worsening respiratory status. He was changed to npo. Unasyn was started due to CXR showing left sided consolidation. SLP was consulted and video swallow was  completed on 03/21/2023 showing mild to moderate oral dysphagia and moderate to severe pharyngeal dysphagia and his diet was changed to a dysphagia diet. He was weaned to room air and transitioned to oral augmentin to complete 5 total days of antibiotics for aspiration/CAP. He discharged back to LTC on 3/23. Decadron was discontinued at discharge (initially started on 3/17) as the patient had been weaned to room air.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Pfizer 3/18/21 Lot# EN6200;  Pfizer 4/8/21 Lot# ER8733;  Pfizer 10/20/21 Lot# 30155BA THIS IS THE INFORMATION AS LISTED IN THE DATABASE
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Pfizer 1/30/21 Lot# EL9261;  PFizer 2/20/21 Lot# EM9810;  Pfizer 10/11/21 Lot# FE3590
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Blood creatinine increased, Blood pressure systolic decreased, Cardiorenal syndrome
Clinical narrative: Discharge Provider: MD Primary Care Provider: PA Admission Date: 4/4/2023 Discharge Date: Apr 8, 2023  PRESENTING PROBLEM: AKI (acute kidney injury) (HCC)   HOSPITAL COURSE: Patient is a 72 y.o. male with past medical history significant for severe CAD s/p CABG and PCI, ischemic cardiomyopathy with combined systolic and diastolic heart failure s/p ICD in 2018, atrial fibrillation on anticoagulation, hypertension, lung cancer, CKD3, type 2 diabetes presents with complaints of increased dizziness with standing and generalized weakness.    Patient was admitted from March 16-17th after having ICD shocks that were occurring over a period of 3 weeks prior. Patient was then re-admitted to the hospital again from March 18-26th with AHRF due to CHF and COVID. His respiratory status improved with diuresis. He has an AKI that failed to improve and his creatinine remained around 2.5-2.9 throughout his admission. Nephrology at that time reported that his kidney function was likely a combination of cardiorenal syndrome and contrast nephropathy. They recommended further diuresis and started torsemide 20mg daily. He has been compliant with this since discharge. He attempted to contact cardiology for assistance who took prolonged time getting back to him and did not give him advice on fluid intake vs restriction. Ultimately contacted nephrology who recommended increased fluids, but given worsening symptoms, presented to the ER for evaluation.    Patient was evaluated by cardiology. They attributed his troponins to AKI and signed off without further input. Nephrology evaluated patient. His torsemide was held. He was given gentle IV fluids. He attempted to work with PT/OT and upon standing systolic BP dropped from 120 to 50's. Later worked with PT/OT and able to go home. As he gentle accumulated fluid, first with IV fluid help, then later only with removal of fluid restriction, his weight slowly increased, renal function drastically improved, and patient felt much improved. Nephrology graciously agreed to be the primary manager of his diuretics moving forward to help with patient's outpatient needs. As he improved he no longer had positive orthostatic vitals. He was discharged in stable condition on 4/8/23.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness postural, Nephropathy toxic, Orthostatic hypotension, Renal impairment, Troponin
Clinical narrative: Discharge Provider: MD Primary Care Provider: PA Admission Date: 4/4/2023 Discharge Date: Apr 8, 2023  PRESENTING PROBLEM: AKI (acute kidney injury) (HCC)   HOSPITAL COURSE: Patient is a 72 y.o. male with past medical history significant for severe CAD s/p CABG and PCI, ischemic cardiomyopathy with combined systolic and diastolic heart failure s/p ICD in 2018, atrial fibrillation on anticoagulation, hypertension, lung cancer, CKD3, type 2 diabetes presents with complaints of increased dizziness with standing and generalized weakness.    Patient was admitted from March 16-17th after having ICD shocks that were occurring over a period of 3 weeks prior. Patient was then re-admitted to the hospital again from March 18-26th with AHRF due to CHF and COVID. His respiratory status improved with diuresis. He has an AKI that failed to improve and his creatinine remained around 2.5-2.9 throughout his admission. Nephrology at that time reported that his kidney function was likely a combination of cardiorenal syndrome and contrast nephropathy. They recommended further diuresis and started torsemide 20mg daily. He has been compliant with this since discharge. He attempted to contact cardiology for assistance who took prolonged time getting back to him and did not give him advice on fluid intake vs restriction. Ultimately contacted nephrology who recommended increased fluids, but given worsening symptoms, presented to the ER for evaluation.    Patient was evaluated by cardiology. They attributed his troponins to AKI and signed off without further input. Nephrology evaluated patient. His torsemide was held. He was given gentle IV fluids. He attempted to work with PT/OT and upon standing systolic BP dropped from 120 to 50's. Later worked with PT/OT and able to go home. As he gentle accumulated fluid, first with IV fluid help, then later only with removal of fluid restriction, his weight slowly increased, renal function drastically improved, and patient felt much improved. Nephrology graciously agreed to be the primary manager of his diuretics moving forward to help with patient's outpatient needs. As he improved he no longer had positive orthostatic vitals. He was discharged in stable condition on 4/8/23.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia, COVID-19, Chills, Groin pain, Malaise
Clinical narrative: My symptoms started with sore throat, head congestion, sneezing. That evening it progressed to a feverish feeling, body aches, and chills. That next morning, I took an at home COVID-19 test that was positive. I called my doctor and the physician assistant prescribed PAXLOVID. I took that for 6 days. My symptoms started improving the first day. I became negative with testing after completing the PAXLOVID regimen. The sneezing also caused a sharp pain in my left hip and groin area.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: My symptoms started with sore throat, head congestion, sneezing. That evening it progressed to a feverish feeling, body aches, and chills. That next morning, I took an at home COVID-19 test that was positive. I called my doctor and the physician assistant prescribed PAXLOVID. I took that for 6 days. My symptoms started improving the first day. I became negative with testing after completing the PAXLOVID regimen. The sneezing also caused a sharp pain in my left hip and groin area.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sneezing
Clinical narrative: My symptoms started with sore throat, head congestion, sneezing. That evening it progressed to a feverish feeling, body aches, and chills. That next morning, I took an at home COVID-19 test that was positive. I called my doctor and the physician assistant prescribed PAXLOVID. I took that for 6 days. My symptoms started improving the first day. I became negative with testing after completing the PAXLOVID regimen. The sneezing also caused a sharp pain in my left hip and groin area.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 9/21/21 Lot# 051E21A;  Moderna 10/19/21 Lot# 017F21A
Age: 77.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Started feeling congested and was coughing. Took home COVID-19 test and was positive. Contacted doctors clinic and was prescribed PAXLOVID. Started feeling better by the next day, then was completely back to normal 4 days later.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 3/3/2 Lot# 023M20A;  Moderna 3/31/21 Lot# 028B21A
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I tested for COVID-19 in 12/2022. I contacted my doctor and got a prescription for Paxlovid. It took over two weeks to get over the congestion. I tolerated the medication without any complications. As of today, I do not have any lingering COVID-19 symptoms.
Age: 53.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect route of product administration, No adverse event
Clinical narrative: The patient did not suffer any ADRs. However, they erroneously received their second dose of the series intramuscularly instead of the ordered route of subcutaneous. Guidance states that this still counts as an effective dose so the patient was not re-immunized.  On review, the information in our records was confusing because the subcutaneous administration instructions contains the word "deltoid". We are removing this confusing word to avoid other causes of intra-deltoid administration.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines  Pfizer 4/3/21 Lot# ER8734;  Pfizer 4/25/21 Lot# Ew0171;  Moderna 12/23/21 Lot# 068H21A
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 3 vaccines Moderna 3/4/21 Lot# 029A21A;  Moderna 4/1/21 Lot# 028A21A ; Moderna 11/26/21 Lot# 012H21B
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Fall, Haematoma, Human metapneumovirus test positive
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 3/16/2023 Discharge Date: Mar 23, 2023  PRESENTING PROBLEM: Acute respiratory insufficiency [R06.89] Infection due to human metapneumovirus (hMPV) [B34.8] COVID-19 [U07.1] Acute respiratory failure due to COVID-19 (HCC) [U07.1, J96.00]   HOSPITAL COURSE:  a 66 y.o. male with a past medical history of Parkinson's disease with psychosis, OSA, reported history of stroke, history of kidney stones, history of DVT typically on Xarelto, hypothyroidism,  and multiple recent falls with recent large right gluteal hematoma 03/02/2023 requiring hospitalization. Patient presented from subacute rehab. with fevers and a fall out of bed.  Patient was reportedly saturating mid 80s on room air at the facility. Upon arrival to the emergency department he was noted to be hypoxemic initially requiring non-rebreather but able to wean down to 4 L nasal cannula.  He was noted to be positive for COVID-19 and metapneumovirus. He was admitted to the internal medicine service. He was started on Remedesivir and dexamethasone. Also received intermittent doses of IV lasix and supportive care. His oxygen was able to be weaned to room air. PT/OT recommended SNF. Patient was discharged on 3/23/2023  5:23 PM
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Metapneumovirus infection, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Discharge Provider:  Primary Care Provider:  Admission Date: 3/16/2023 Discharge Date: Mar 23, 2023  PRESENTING PROBLEM: Acute respiratory insufficiency [R06.89] Infection due to human metapneumovirus (hMPV) [B34.8] COVID-19 [U07.1] Acute respiratory failure due to COVID-19 (HCC) [U07.1, J96.00]   HOSPITAL COURSE:  a 66 y.o. male with a past medical history of Parkinson's disease with psychosis, OSA, reported history of stroke, history of kidney stones, history of DVT typically on Xarelto, hypothyroidism,  and multiple recent falls with recent large right gluteal hematoma 03/02/2023 requiring hospitalization. Patient presented from subacute rehab. with fevers and a fall out of bed.  Patient was reportedly saturating mid 80s on room air at the facility. Upon arrival to the emergency department he was noted to be hypoxemic initially requiring non-rebreather but able to wean down to 4 L nasal cannula.  He was noted to be positive for COVID-19 and metapneumovirus. He was admitted to the internal medicine service. He was started on Remedesivir and dexamethasone. Also received intermittent doses of IV lasix and supportive care. His oxygen was able to be weaned to room air. PT/OT recommended SNF. Patient was discharged on 3/23/2023  5:23 PM
Age: 12.0
Sex: M
Vaccine: FLU4, HPV9, IPV, MNQ, TDAP
Symptoms: Peripheral swelling, Pruritus
Clinical narrative: 45 minutes after vaccination at 1053am patient reported swelling in his right forearm and itching across his chest and on his upper arms. Patient denied shortness of breath, difficulty breathing and was alert and oriented x4. Vital signs stable. 1056am 130/100 hr 83 SpO2 97% ra respiratory rate 20bpm. At 1058am MPOA approved one time dose of Benadryl 25mg PO, nurse obtained through standing orders, patient able to self-administer without any difficulty. Vital signs were rechecked at 1106am and continued to be stable 108/80, 78 heart rate, 94% SpO2 and respiratory rate 14bpm. MPOA educated on acute signs and symptoms that would warrant immediate medical attention MPOA verbalized understanding and denied questions. The patient declined the need to lay down and was ready to rejoin his group in the waiting room. VAERS forms completed, Medical Officer notified and clinical services adverse event form completed.
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arteriogram coronary abnormal, Arteriosclerosis coronary artery, Bradycardia, Coronary angioplasty, Dizziness
Clinical narrative: In January of 2023, I had to angioplasty procedure to replace five stents in my heart My cardiologist felt that with the with increase fatigue, lightheadedness, I needed to have an angiogram. The angiogram showed that my stents were in need of being replaced. They did the first of the replacements on January 13, 2023, the same day as the angiogram. The second surgery was on January 31, 2023. I am currently in cardiac rehab; I do have tachycardia and bradycardia now.
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Stent placement, Surgery, Tachycardia
Clinical narrative: In January of 2023, I had to angioplasty procedure to replace five stents in my heart My cardiologist felt that with the with increase fatigue, lightheadedness, I needed to have an angiogram. The angiogram showed that my stents were in need of being replaced. They did the first of the replacements on January 13, 2023, the same day as the angiogram. The second surgery was on January 31, 2023. I am currently in cardiac rehab; I do have tachycardia and bradycardia now.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: vaccine was outdated - no adverse reaction
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 2/21/21 NO LOT #;  Moderna 3/21/21 NO LOT# THERE WERE NO LOT NUMBERS DOCUMENTED IN THE DATABASE
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Headache, Malaise, Respiratory tract congestion
Clinical narrative: 03/25/2023 I started having congestion, head ache and mild cough. After testing positive for Covid-19 I was prescribed Paxlovid. Symptoms lasted about  17 days. Since testing negative on 04/05/2023 i had a rebound with symptoms that lasted a week.
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 03/25/2023 I started having congestion, head ache and mild cough. After testing positive for Covid-19 I was prescribed Paxlovid. Symptoms lasted about  17 days. Since testing negative on 04/05/2023 i had a rebound with symptoms that lasted a week.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: According to clinic, patient had receivied J&J primary vaccination 4/1/2021. Pfizer MV was given 1/12/2023 and again 1/30/2023.  Bivalent was the recommended instead of MV.  Bivalent was given today 4/13/2023.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: COVID-19, Cough, Ear pain, Fatigue, Headache
Clinical narrative: I had symptoms on the 26th and tested positive on the 27th of January. I had headache and a dry cough. When I decided to test the symptoms worsened, and tested because I had an appointment. I called my PCP and they said to use any over the counter medication for headache relief and isolate for 5 days. Basically, wait to feel better and test after 10 days. I got sicker during isolation and called a on call doctor, and we discussed taking Paxlovid and that's what I did. I was so sick that during the five days of taking it left a terrible taste. I had more symptoms during that time as well. I had mark malaise, fatigue and a productive cough that was painful in my throat and ears. The headache was quite bad. By the time I finished the Paxlovid, in terms of symptoms they did back off a little. I feel good now.
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Malaise, Oropharyngeal pain, Productive cough, SARS-CoV-2 test positive
Clinical narrative: I had symptoms on the 26th and tested positive on the 27th of January. I had headache and a dry cough. When I decided to test the symptoms worsened, and tested because I had an appointment. I called my PCP and they said to use any over the counter medication for headache relief and isolate for 5 days. Basically, wait to feel better and test after 10 days. I got sicker during isolation and called a on call doctor, and we discussed taking Paxlovid and that's what I did. I was so sick that during the five days of taking it left a terrible taste. I had more symptoms during that time as well. I had mark malaise, fatigue and a productive cough that was painful in my throat and ears. The headache was quite bad. By the time I finished the Paxlovid, in terms of symptoms they did back off a little. I feel good now.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired vaccine - no reaction
Age: 97.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines Moderna 1/14/21 Lot# 012L20A;  Moderna 2/11/21 Lot# 010M20A
Age: 88.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine, Blood lactic acid, Blood pH decreased
Clinical narrative: Discharge Provider: MD Primary Care Physician at Discharge: FNP Admission Date: 3/16/2023  PRESENTING PROBLEM: Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) [J96.21, J96.22]   HOSPITAL COURSE: Patient is a 88 y.o. female, patient of FNP who presented with increasing SHOB and cough the past few weeks with more sleepiness the past few days. She is chronically ill with diastolic heart failure, diabetes mellitus controlled, idiopathic pulmonary fibrosis/on 2L continuous, chronic lower leg lymphedema with recurrent wounds, chronic kidney disease stage IV-V (follows with Nephrology). She was diagnosed with UTI on Mar 10 and started on ciprofloxacin, cultures confirmed it is susceptible.   In the ED, she was severely dyspneic. She was placed on BiPap. CXR showing pulmonary vascular congestion and bilateral pleural effusions. Labs revealing pH 7.20, pCO2 70, with worsening renal function, creatinine 3.15 (usuaally 2.30 - 2.70) and BUN 115, along with lactate 4.1, potassium 5.4. BNP quite elevated at 46,000. She was given breathing treatments, Lasix, Solumedrol and Bipap. Unfortunately, she did test (+) for Covid. She requires admission for a/c heart failure, a/c renal failure.    Daughter at bedside, very involved in care, visits her mom at facility daily and is often caring for her wounds. She explains that her mom recently had code discussion and wished to be DNR. She also would not want dialysis. Palliative care/hospice care also broached with PCP, however daughter didn't feel her mom was ready for that stage of care, as she doesn't have any chronic pain.    The patient was treated with oxygen which needed to be progressed to BiPAP for her respiratory failure, and she also developed hypotension requiring norepinephrine.  She had progressive confusion and decreasing urine output and worsening renal failure, and after discussion in regards to very poor prognosis decision was made to transition her to comfort care measures.  She was treated with norepinephrine while her daughter was trying to arrived to see her from another state, but was otherwise treated with comfort care measures beginning on 03/19/2020.  On 03/20/2020 her norepinephrine was discontinued and her oxygen was also removed.  She was treated with IV Ativan and morphine for distress, and passed away with family at bedside at 11:10 a.m..